Filing Details

Accession Number:
0001477932-22-004498
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 16:05:26
Reporting Period:
2022-05-01
Accepted Time:
2022-06-17 16:05:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834339 Thomas Salvatore Butera 13215 Bee Cave Parkway,
Suite 125, Galleria Oaks B
Austin TX 78738
Ceo - Volition Veterinary No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-01 15,000 $2.79 145,000 No 4 F Direct
Common Stock Acquisiton 2022-06-16 10,000 $2.05 155,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,000 Direct
Footnotes
  1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 50,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
  2. These shares of common stock are jointly owned by the reporting person and his spouse.